<DOC>
	<DOCNO>NCT01395199</DOCNO>
	<brief_summary>This study aim investigate use amlodipine , drug block uptake calcium cell , prevention treatment iron overload patient thalassemia major . Since iron use calcium channel enter heart , pancreas organ , block channel might help prevent accumulation iron tissue . The study follow 60 patient thalassemia major : 30 receive amlodipine 30 serve control receive placebo randomize double-blind fashion . Patients monitor one year . Monitoring occur measurement blood ferritin well live heart T2* MRI initially , 6 12 month .</brief_summary>
	<brief_title>Amlodipine Prevention Treatment Iron Overload Patients With Thalassemia Major</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Patients thalassemia major least 6 year age undergoing iron chelation therapy . 2 . No anticipated change chelation regimen next 12 month 3 . Completed sign Informed Consent 1 . Pregnancy 2 . Advanced class III/IV heart failure LVEF &lt; 0.35 % ( MRI ) 3 . Formal contraindication MRI ( pacemaker , cerebral aneurysm metal clip , etc ) . 4 . Advanced heart AV block</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Magnetic resonance imaging</keyword>
	<keyword>Thalassemia</keyword>
	<keyword>Iron overload</keyword>
</DOC>